These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15925430)

  • 1. Design, synthesis and bioactivities of TAR RNA targeting beta-carboline derivatives based on Tat-TAR interaction.
    Yu X; Lin W; Pang R; Yang M
    Eur J Med Chem; 2005 Sep; 40(9):831-9. PubMed ID: 15925430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel beta-carboline derivatives as Tat-TAR interaction inhibitors.
    Yu X; Lin W; Li J; Yang M
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3127-30. PubMed ID: 15149658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and assay of isoquinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
    He M; Yuan D; Lin W; Pang R; Yu X; Yang M
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3978-81. PubMed ID: 16039124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and SAR of new substituted purines bearing aryl groups at N9 position as HIV-1 Tat-TAR interaction inhibitors.
    Pang R; Zhang C; Yuan D; Yang M
    Bioorg Med Chem; 2008 Sep; 16(17):8178-86. PubMed ID: 18693018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
    Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
    Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
    Chen S; Chen R; He M; Pang R; Tan Z; Yang M
    Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The design, synthesis, and biological evaluation of novel substituted purines as HIV-1 Tat-TAR inhibitors.
    Yuan D; He M; Pang R; Lin SS; Li Z; Yang M
    Bioorg Med Chem; 2007 Jan; 15(1):265-72. PubMed ID: 17055732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.
    Hamy F; Brondani V; Flörsheimer A; Stark W; Blommers MJ; Klimkait T
    Biochemistry; 1998 Apr; 37(15):5086-95. PubMed ID: 9548739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotide analogue interference with the HIV-1 Tat protein-TAR RNA interaction.
    Arzumanov A; Walsh AP; Liu X; Rajwanshi VK; Wengel J; Gait MJ
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):471-80. PubMed ID: 11563062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
    Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino disaccharides having an alpha-(1-->4) or a beta-(1-->4) linkage, their synthesis and evaluation as a potential inhibitor for HIV-1 TAR-Tat.
    Iguchi T; Ishikawa H; Matumoto H; Mizuno M; Goto K; Hamasaki K
    Nucleic Acids Symp Ser (Oxf); 2005; (49):169-70. PubMed ID: 17150687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
    Yang M
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.
    Lind KE; Du Z; Fujinaga K; Peterlin BM; James TL
    Chem Biol; 2002 Feb; 9(2):185-93. PubMed ID: 11880033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.
    Murchie AI; Davis B; Isel C; Afshar M; Drysdale MJ; Bower J; Potter AJ; Starkey ID; Swarbrick TM; Mirza S; Prescott CD; Vaglio P; Aboul-ela F; Karn J
    J Mol Biol; 2004 Feb; 336(3):625-38. PubMed ID: 15095977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase synthesis and evaluation of TAR RNA targeted beta-carboline-nucleoside conjugates.
    Zhao P; Jin HW; Yang ZJ; Zhang LR; Zhang LH
    Org Biomol Chem; 2008 Oct; 6(20):3741-50. PubMed ID: 18843404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
    Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence correlation spectroscopy at single molecule level on the Tat-TAR complex and its inhibitors.
    Nandi CK; Parui PP; Brutschy B; Scheffer U; Göbel M
    Biopolymers; 2008 Jan; 89(1):17-25. PubMed ID: 17764074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of generation 2-5 of PAMAM dendrimer on the inhibition of Tat peptide/ TAR RNA binding in HIV-1 transcription.
    Wang W; Guo Z; Chen Y; Liu T; Jiang L
    Chem Biol Drug Des; 2006 Dec; 68(6):314-8. PubMed ID: 17177893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction.
    Gatto B; Tabarrini O; Massari S; Giaretta G; Sabatini S; Del Vecchio C; Parolin C; Fravolini A; Palumbo M; Cecchetti V
    ChemMedChem; 2009 Jun; 4(6):935-8. PubMed ID: 19283692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New inhibitors of the Tat-TAR RNA interaction found with a "fuzzy" pharmacophore model.
    Renner S; Ludwig V; Boden O; Scheffer U; Göbel M; Schneider G
    Chembiochem; 2005 Jun; 6(6):1119-25. PubMed ID: 15883975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.